Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
Ecopipam hydrochloride
Cat. No.:
OB0425LY-150
Appearance:
Solid
Purity:
99.46%
Identity:
Confirmed by NMR and LC-MS.
Size:
Add to basket
Product Overview
Description:
Ecopipam hydrochloride is a small molecule with neuroprotective effects mainly as a selective dopamine D1 receptor antagonist.
Synonyms:
190133-94-9; Ecopipam HCl; Sch 39166; Ecopipam (hydrochloride); 5H-Benzo[d]naphth[2,1-b]azepin-12-ol, 11-chloro-6,6a,7,8,9,13b-hexahydro-7-methyl-, hydrochloride (1:1), (6aS,13bR)-
CAS No.:
190133-94-9
Compound CID:
170317
Formula:
C19H21Cl2NO
Formula Weight:
350.28
Specification
Target:
Dopamine receptor; 5-HT receptor; Adrenergic receptor
Pathway:
GPCR/G protein; Neuronal signaling
Solubility:
DMSO
Storage:
Storage at 4°C.
Applications:
Ecopipam hydrochloride can be used in studies of psychiatric disorders such as depression and other disorders associated with dopamine dysfunction studies.
